A Double-Blind, Randomized, Placebo-Controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of L2-01 in Subjects With Crohn's Disease

Clinical trial NCT07010926 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07010926
Sponsor: L2 Bio, LLC
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Crohn&Amp;#39;s Crohn&Amp;#39;s Disease (CD)

Start date: 2025-08-15
Primary completion: 2026-12-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.